Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 342,488 | 263,180 | 316,827 | 228,713 | 173,016 |
| Marketable Securities | 72,715 | 174,809 | 198,563 | 67,546 | 0 |
| Receivables | 131,227 | 119,711 | 112,130 | 106,843 | 94,242 |
| Inventories | 24,156 | 24,277 | 23,395 | 29,526 | 14,405 |
| Other current assets | 8,239 | 8,077 | 18,239 | 4,555 | 2,748 |
| TOTAL | $596,812 | $605,291 | $681,508 | $448,730 | $290,738 |
| Non-Current Assets | |||||
| PPE Net | 92,012 | 102,499 | 109,465 | 85,873 | 64,188 |
| Investments And Advances | 0 | 0 | 0 | 29,555 | 0 |
| Intangibles | 895,894 | 931,026 | 969,440 | 331,736 | 325,241 |
| Other Non-Current Assets | 96,511 | 101,218 | 109,365 | 92,437 | 29,339 |
| TOTAL | $1,084,417 | $1,134,743 | $1,188,270 | $539,601 | $418,768 |
| Total Assets | $1,681,229 | $1,740,034 | $1,869,778 | $988,331 | $709,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 5,000 |
| Accounts payable and accrued liabilities | 20,334 | 20,510 | 17,921 | 24,965 | 19,568 |
| Accrued Expenses | 68,230 | 55,211 | 56,100 | 36,381 | 28,913 |
| Other current liabilities | 2,130 | 7,557 | 5,192 | 4,029 | 1,610 |
| TOTAL | $96,304 | $89,932 | $87,232 | $73,183 | $63,904 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 91,829 |
| Other Non-Current Liabilities | 619,103 | 617,329 | 618,794 | 214,472 | 27,600 |
| TOTAL | $643,388 | $652,079 | $674,269 | $220,854 | $138,194 |
| Total Liabilities | $739,692 | $742,011 | $761,501 | $294,037 | $202,098 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,610 | 127,458 | 124,026 | 116,940 | 104,832 |
| Common Shares | 127 | 127 | 124 | 112 | 105 |
| Retained earnings | -247,055 | -159,087 | -14,837 | -7,185 | -11,357 |
| Other shareholders' equity | -1,674 | -3,899 | -638 | 10 | -1,618 |
| TOTAL | $941,537 | $998,023 | $1,108,277 | $694,294 | $507,408 |
| Total Liabilities And Equity | $1,681,229 | $1,740,034 | $1,869,778 | $988,331 | $709,506 |